Multiple pathways to cellular senescence: Role of telomerase repressors

European Journal of Cancer Part A

Volumn 33, Issue 5, 1997, Pages 710-715

  Oshimura, M ^a   Barrett, J C ^b  

^a TOTTORI UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

cellular senescence; microcell mediated chromosome transfer; multiple pathways; telomerase; telomere

Indexed keywords

TELOMERASE;

ARTICLE; CARCINOGENESIS; CELL AGING; CELL PROLIFERATION; CHROMOSOME 3; CHROMOSOME TRANSLOCATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GROWTH REGULATION; HUMAN; KIDNEY CARCINOMA; NONHUMAN; PRIORITY JOURNAL; TELOMERE;

ANIMALS; CELL AGING; CELL DIVISION; CELL FUSION; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; SEQUENCE DELETION; TELOMERASE; TELOMERE;

EID: 0030979581     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00090-7     Document Type: Article

References (50)

1. Saxon PJ, Srivatson ES, Leipzing GV, Sameshima JH, Stanbridge EJ. Selective transfer of individual human chromosomes to recipient cells. Mol Cell Biol 1985, 5, 140-146.
2. Kugoh EM, Hashiba H, Shimizu M, Oshimura M. Suggestive evidence for functionally distinct, tumor-suppressor genes on chromosome 1 and 11 for a human fibrosarcoma cell line, HT1080. Oncogene 1990, 5, 1637-1644.
3. Oshimura M, Kugoh MH, Shimizu M, Yamada H, Horikawa I, Sasaki M. Multiple chromosomes carrying tumor suppressor activity, via microcell-mediated chromosome transfer, for various tumour cell lines. In Knudson AG, Stanbridge EJ, Sugimura T, Terada M, Watanabe S, eds. Genetic Basis for Carcinogenesis, Tumour Suppressor Genes and Oncogenes. Tokyo, Jpn Sei Soc Press; London and Bristol, Taylor & Francis, 1990, 249-255.
4. Goyetee MC, Cho K, Fashing C, et al. Progression of colorectal cancer is associated with multiple tumour suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol Cell Biol 1992, 12, 1387-1395.
5. Sasaki M, Honda T, Yamada H, Wake N, Barrett JC, Oshimura M. Evidence for multiple pathways to cellular senescence. Cancer Res 1994, 54, 6090-6093.
6. Sugaware O, Oshimura M, Koi M, Annab LA, Barrett JC. Introduction of cellular senescence in immortalised cells by human chromosome 1. Science 1990, 247, 707-710.
7. Kurimasa A, Nagata Y, Shimizu M, Emi M, Nakamura Y, Oshimura M. A human gene that restores the DNA-repair defect in SCID mice is located on 8p 11.1-8q11.1. Hum Genet 1994, 93, 21-26.
8. Oshimura M, Kurimasa A. Studies on tumour suppression by microcell-mediated chromosome transfer. Cancer Chemother 1992, 7, 52-54.
9. Ichikawa T, Nihei N, Kuramochi H, et al. Metastatic suppressor genes for prostate cancer. The Prostate Supplement 1996, 6, 31-35.
10. Hayflick L. The cell biology of human aging. N Engl J Med 1976, 295, 1302-1308.
11. Daniel CW, De Orne KB, Yung JT, Blair PB, Faulkin JJ Jr. The in vivo span of normal and preneoplastic mouse mammary glands: a serial transplantation study. Proc Natl Acad Sci USA 1968, 61, 53-60.
12. Barrett JC. Cell senescence and apoptosis. In Levine AJ, Schmideck HH, eds. Molecular Genetics of Nervous System Tumours. New York, Wiley-Liss, 1993, 61-72.
13. Barrett JC, Ts'o POP. Evidence for the progressive nature of neoplastic transformation. Proc Natl Acad Sci USA 1978, 75, 3761-3765.
14. Barrett JC. A preneoplastic stage in the spontaneous neoplastic transformation of Syrian hamster embryo cells in culture. Cancer Res 1980, 40, 91-94.
15. Newbold RF, Overell RW. Fibroblast immortality is a prerequisite for transformation of EJ c-Ha-ras oncogene. Nature 1983, 304, 648-651.
16. Pereira-Smith OM, Smith JR. Evidence for the recessive nature of cellular immortality. Science 1983, 221, 964-966.
17. Ning Y, Weber JL, Killary AM, Ledbetter DH, Smith JR, Pereira-Smith OM. Genetic analysis of indefinite division in human cells: evidence for a cell senescence-related gene(s) on human chromosome 4. Proc Natl Acad Sci USA 1991, 8, 5635-5639.
18. Koi M, Johnson LA, Kalikin LM, Little PFR, Nakamura Y, Feinberg AP. Tumour cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11. Science 1993, 260, 361-364.
19. Ogata T, Ayusawa D, Namba M, Takahashi E, Oshimura M, Oishi M. Chromosome 7 suppresses indefinite division of non-tumorigenic immortalised human fibroblast cell lines KMST-6 and SUSM-1. Mo1 Cell Biol 1993, 13, 6036-6043.
20. Sandhu AK, Hubbard K, Kaur GP, Jha KK, Ozor HL, Athwal RS. Senescence of immortal human fibroblast by the introduction of normal human chromosome 6. Proc Natl Acad Sci USA 1994, 91, 5498-5502.
21. Yoshida MA, Shimizu M, Ikeuchi T, Tonomura A, Yokota J, Oshimura M. In vitro growth suppression and morphological change in a human renal cell carcinoma cell line by the introduction of normal chromosome 3 via microcell fusion. Mol Carcinogen 1994, 9, 114-121.
22. Uejima H, Mitsuya K, Kugoh H, Horikawa I, Oshimura M. Normal human chromosome 2 induces cellular senescence in the human cervical carcinoma cell line SiHa. Genes Chromosomes Cancer 1995, 14, 120-127.
23. Hensler PJ, Annab LA, Barrett JC, Pereira-Smith OM. A gene involved in the control of cellular senescence localised to human chromosome 1q. Mol Cell Biol 1994, 14, 2291-2297.
24. Yamada H, Wake N, Fujimoto S, Barrett JC, Oshimura M. Multiple chromosomes carrying tumour supressor activity for a uterine endometrial carcinoma cell line identified by microcell-mediated chromosome transfer. Oncogene 1990, 5, 1141-1147.
25. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345, 458-460.
26. Counter CM, Avilion AA, LeFeuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992, 11, 1921-1929.
27. Lange TD. Activation of telomerase in a human tumour. Proc Natl Acad Sci USA 1994, 91, 2882-2885.
28. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266, 2011-2015.
29. Wright WE, Shay JW, Piatyszek M. Modification of a telomeric repeat amplification protocol (TRAP) results in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995, 23, 3794-3795.
30. Vojta PJ, Futreal PA, Annab LA, Kato H, Pereira-Smith OM, Barrett JC. Evidence for the two senescence loci on human chromosome 1. Genes Chromosomes Cancer 1996, 16, 55-63.
31. Wright WE, Shay JW. The two-stage mechanism controlling cellular senescence and immortalisation. Exp Gerontol 1992, 27, 383-389.
32. Moyer AW, Wallace R, Cox HR. Limited growth period of human lung cell lines transformed by simian virus 40. J Natl Cancer Inst 1964, 44, 227-236.
33. Hubbard-Smith K, Patsalis P, Pardinas JR, Jha KK, Henderson AS, Ozer HL. Altered chromosome 6 in immortal human fibroblasts. Mol Cell Biol 1992, 12, 2273-2281.
34. Goolsby CL, Wiley JE, Steiner M, Bartholdi MF, Cram LS, Kraemer PM. Karyotype evolution in a simian virus 40-transformed tumorigenic human cell line. Cancer Genet Cytogenet 1991, 49, 231-248.
35. Hara E, Tsurui H, Shinozaki A, Nadada S, Oda K. Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts. Biochem Biophys Res Commun 1991, 179, 528-534.
36. Thomassen DG, Barrett JC, Nettesheim P. Changes in stem cell populations of rat epithelial cell cultures at an early stage in neoplastic progression. Cancer Res 1985, 45, 3322-3331.
37. Bols BL, Naaktgeboren JM, Simons JW. Immortalisation of Syrian hamster embryo cells is in itself a multistep event. Cancer Res 1991, 51, 1177-1184.
38. Duncan EJ, Whitaker NJ, Moy EL, Reddel RR. Assignment of SV40-immortalised cells to more than one complementation group for immortalisation. Exp Cell Res 1993, 205, 337-344.
39. Berry IJ, Burns JE, Parkinson EK. Assignment of two human epidermal squamous cell carcinoma cell lines to more than one complementation group for the immortal phenotype. Mol Carcinogen 1994, 9, 134-142.
40. Blackburn EH. Structure and function of telomeres. Nature 1991, 350, 569-573.
41. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992, 89, 10114-10118.
42. Ohmura H, Tahara H, Suzuki M, et al. Restoration of the cellular senescence programme and repression of telomerase by human chromosome 3. Jpn J Cancer Res 1995, 86, 899-901.
43. Harley CB, Vaziri H, Counter CM, Allsopp RC. The telomere hypothesis of cellular aging. Exp Gerontol 1992, 27, 375-382.
44. Shay JW, Tomlinson G, Piatyszek MA, Gollahon LS. Spontaneous in vitro immortalisation of breast epithelial cells from a patient with Li-Fraumeni syndrome. Mol Cell Biol 1995, 15, 425-432.
45. Wright WE, Shay JW. Telomere positional effects and the regulation of cellular senescence. Trends Genet 1992, 8, 193-197.
46. Goldstein S. Replicative senescence: the human fibroblast comes of age. Science 1990, 249, 1129-1133.
47. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965, 37, 614-636.
48. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesises TTAGGG repeats. Cell 1989, 59, 521-529.
49. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S. Stabilisation of short telomeres and telomerase activity accompany immortalisation of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994, 68, 3410-3414.
50. Counter CM, Hirle HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994, 91, 2900-2904.